IONS
IONIS PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$44.44
−4.94%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$1.00
- Revenue estimate
- $181.8M
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- -$0.69
- EPS estimate
- -$1.08
- Revenue actual
- $268.0M
- Revenue estimate
- $189.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +68.6%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $88
- PT range
- $54 – $129
- Analysts
- 15
12 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | -$1.08 | -$0.69 | Beat 36.11% | $268.0M |
| Apr 29, 2026 | -$0.85 | -$0.56 | Beat 34.12% | $246.0M |
| Feb 25, 2026 | -$1.24 | -$1.41 | Miss -14.31% | $203.0M |
| Oct 28, 2025 | — | -$0.80 | — | $156.7M |
| Jul 30, 2025 | $0.27 | $0.86 | Beat 218.52% | $452.0M |
| Apr 30, 2025 | -$1.11 | -$0.75 | Beat 32.43% | $131.6M |
| Feb 19, 2025 | -$1.09 | -$0.66 | Beat 39.45% | $226.6M |
| Aug 1, 2024 | -$0.92 | -$0.45 | Beat 51.09% | $225.3M |
| Feb 21, 2024 | -$0.83 | -$0.06 | Beat 92.77% | $324.5M |
| Nov 2, 2023 | -$1.04 | -$1.03 | Beat 0.96% | $144.2M |
| May 3, 2023 | -$0.91 | -$0.87 | Beat 4.40% | $130.5M |
| Feb 22, 2023 | -$1.06 | -$0.37 | Beat 65.09% | $151.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026